López Barrera, L.D.; Santillan Morales, K.Y.; Martínez Rosas, J.R.; Soria-Castro, E.; Ramírez Noguera, P.; Ganem Rondero, F.A.; Diaz-Torres, R.
Development and Characterization of Polylactic Acid-Resveratrol-Based Polymeric Nanoparticles and Their Cytotoxic Effect on Two Breast Cancer Cell Lines in Combination with Doxorubicin. Pharmaceutics 2026, 18, 974.
https://doi.org/10.3390/pharmaceutics18080974
AMA Style
López Barrera LD, Santillan Morales KY, Martínez Rosas JR, Soria-Castro E, Ramírez Noguera P, Ganem Rondero FA, Diaz-Torres R.
Development and Characterization of Polylactic Acid-Resveratrol-Based Polymeric Nanoparticles and Their Cytotoxic Effect on Two Breast Cancer Cell Lines in Combination with Doxorubicin. Pharmaceutics. 2026; 18(8):974.
https://doi.org/10.3390/pharmaceutics18080974
Chicago/Turabian Style
López Barrera, Laura Denise, Kevin Yair Santillan Morales, Joselo Ramón Martínez Rosas, Elizabeth Soria-Castro, Patricia Ramírez Noguera, Flora Adriana Ganem Rondero, and Roberto Diaz-Torres.
2026. "Development and Characterization of Polylactic Acid-Resveratrol-Based Polymeric Nanoparticles and Their Cytotoxic Effect on Two Breast Cancer Cell Lines in Combination with Doxorubicin" Pharmaceutics 18, no. 8: 974.
https://doi.org/10.3390/pharmaceutics18080974
APA Style
López Barrera, L. D., Santillan Morales, K. Y., Martínez Rosas, J. R., Soria-Castro, E., Ramírez Noguera, P., Ganem Rondero, F. A., & Diaz-Torres, R.
(2026). Development and Characterization of Polylactic Acid-Resveratrol-Based Polymeric Nanoparticles and Their Cytotoxic Effect on Two Breast Cancer Cell Lines in Combination with Doxorubicin. Pharmaceutics, 18(8), 974.
https://doi.org/10.3390/pharmaceutics18080974
